KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Non-Current Assets (2016 - 2026)

Abbott Laboratories' Non-Current Assets history spans 18 years, with the latest figure at $84.9 billion for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 45.67% to $84.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $264.5 billion, a 22.17% increase, with the full-year FY2025 number at $60.7 billion, up 5.12% from a year prior.
  • Non-Current Assets hit $84.9 billion in Q1 2026 for Abbott Laboratories, up from $60.7 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for ABT hit a ceiling of $84.9 billion in Q1 2026 and a floor of -$22.3 billion in Q4 2022.
  • Historically, Non-Current Assets has averaged $50.3 billion across 5 years, with a median of $50.5 billion in 2023.
  • Biggest five-year swings in Non-Current Assets: plummeted 270.54% in 2022 and later skyrocketed 326.24% in 2023.
  • Tracing ABT's Non-Current Assets over 5 years: stood at -$22.3 billion in 2022, then skyrocketed by 326.24% to $50.5 billion in 2023, then rose by 14.27% to $57.8 billion in 2024, then increased by 5.12% to $60.7 billion in 2025, then skyrocketed by 39.86% to $84.9 billion in 2026.
  • Business Quant data shows Non-Current Assets for ABT at $84.9 billion in Q1 2026, $60.7 billion in Q4 2025, and $59.3 billion in Q3 2025.